- Home
- WHLR vs ONCO Comparison
WHLR vs ONCO Comparison
Compare WHLR & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WHLR | ONCO |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | United States | United States |
| Employees | 56 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3M | 2.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | WHLR | ONCO |
|---|---|---|
| Price | $1.86 | $0.76 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 430.7K | 229.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,524,116.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.01 | ★ N/A |
| Revenue Growth | N/A | ★ 4217.31 |
| 52 Week Low | $0.65 | $0.05 |
| 52 Week High | $10.05 | $7.65 |
Technical Indicators
Market Signals| Indicator | WHLR | ONCO |
|---|---|---|
| Relative Strength Index (RSI) | 40.59 | 36.81 |
| Support Level | $1.82 | $0.62 |
| Resistance Level | $2.25 | $1.87 |
| Average True Range (ATR) | 0.23 | 0.17 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 30.69 | 8.30 |
Price Performance
Historical ComparisonAbout WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.